Ad
related to: AstraZeneca
Search results
AstraZeneca (AZN) Falls on Failure to Meet NSCLC Study OS Goal
Zacks· 3 days agoAstraZeneca's (AZN) shares decline as it fails to achieve statistically significant overall survival data in a late-stage NSCLC study on Dato-DXd compared with docetaxel.
Earnings call: Cellectis reports an additional investment of $140 million from AstraZeneca By...
Investing.com· 2 days agoIn their first quarter 2024 earnings call, Cellectis, a biopharmaceutical company, presented a...
JPMorgan bullish on AstraZeneca stock, highlights AZD0780's sales By Investing.com
Investing.com· 4 days agoOn Tuesday, JPMorgan (NYSE:JPM) maintained its positive stance on AstraZeneca (NASDAQ:AZN:LN)...
AstraZeneca started at buy at Goldman, which rates GSK a neutral
Market Watch· 2 days agoGoldman Sachs started coverage of AstraZeneca at buy as it rated rival pharmaceutical company GSK a...
Compugen hits milestone with AstraZeneca cancer trial By Investing.com
Investing.com· 2 days agoThe trial is a crucial step in evaluating the drug as a first-line treatment for a specific type of...
Parallel Advisors LLC Sells 169 Shares of AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 2 days agoParallel Advisors LLC reduced its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 1.2% during the fourth quarter, according to the company in its most recent 13F filing ...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga via Yahoo Finance· 3 days agoTuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first...
Commerce Bank Trims Holdings in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 3 days agoCommerce Bank lessened its stake in AstraZeneca PLC (NASDAQ:AZN – Free Report) by 10.6% in the 4th quarter, according to the company in its most recent filing with the Securities ...
AstraZeneca’s (AZN) “Buy” Rating Reaffirmed at Citigroup
ETF DAILY NEWS· 4 days agoCitigroup reissued their buy rating on shares of AstraZeneca (LON:AZN – Free Report) in a report published on Tuesday, Marketbeat reports. Several other analysts have also ...
AstraZeneca and Daiichi Sankyo’s ADC improves survival in NSCLC trial
Clinical Trials Arena via Yahoo Finance· 5 days agoAstraZeneca and Daiichi Sankyo have reported high-level overall survival (OS) results from the Phase...